These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 12827262)

  • 21. Dynamic magnetic resonance tomography and proton magnetic resonance spectroscopy of prostate cancers in rats treated by radiotherapy.
    Kiessling F; Huber PE; Grobholz R; Heilmann M; Meding J; Lichy MP; Fink C; Krix M; Peschke P; Schlemmer HP
    Invest Radiol; 2004 Jan; 39(1):34-44. PubMed ID: 14701987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Description of magnetic resonance imaging-derived enhancement variables in pathologically confirmed prostate cancer and normal peripheral zone regions.
    Zelhof B; Lowry M; Rodrigues G; Kraus S; Turnbull L
    BJU Int; 2009 Sep; 104(5):621-7. PubMed ID: 19281464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of semi-quantitative dynamic contrast-enhanced MRI parameters for prostate cancer in correlation to whole-mount histopathology.
    Isebaert S; De Keyzer F; Haustermans K; Lerut E; Roskams T; Roebben I; Van Poppel H; Joniau S; Oyen R
    Eur J Radiol; 2012 Mar; 81(3):e217-22. PubMed ID: 21349667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical value of native and contrast enhanced MRI in staging prostatic carcinoma before planned radical prostatectomy].
    Kuhn M; Huttmann P; Spielhaupter E; Gross-Fengels W; Schreiter F
    Rofo; 2001 Jul; 173(7):595-600. PubMed ID: 11512230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI.
    Langer DL; van der Kwast TH; Evans AJ; Trachtenberg J; Wilson BC; Haider MA
    J Magn Reson Imaging; 2009 Aug; 30(2):327-34. PubMed ID: 19629981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate cancer: evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging--initial experience.
    Buckley DL; Roberts C; Parker GJ; Logue JP; Hutchinson CE
    Radiology; 2004 Dec; 233(3):709-15. PubMed ID: 15498903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The value of dynamic MRI studies in parotid tumors.
    Alibek S; Zenk J; Bozzato A; Lell M; Grunewald M; Anders K; Rabe C; Iro H; Bautz W; Greess H
    Acad Radiol; 2007 Jun; 14(6):701-10. PubMed ID: 17502260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging.
    Delongchamps NB; Rouanne M; Flam T; Beuvon F; Liberatore M; Zerbib M; Cornud F
    BJU Int; 2011 May; 107(9):1411-8. PubMed ID: 21044250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simple models improve the discrimination of prostate cancers from the peripheral gland by T1-weighted dynamic MRI.
    Kiessling F; Lichy M; Grobholz R; Heilmann M; Farhan N; Michel MS; Trojan L; Ederle J; Abel U; Kauczor HU; Semmler W; Delorme S
    Eur Radiol; 2004 Oct; 14(10):1793-801. PubMed ID: 15232714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Staging of prostate cancer: value of the combined information of endorectal MRI, biopsy Gleason score, and preoperative PSA level].
    Wetter A; Ajdukovic AN; Fliessbach K; Lehnert T; Engl T; Jacobi V; Vogl TJ
    Rofo; 2006 Apr; 178(4):385-90. PubMed ID: 16607587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic contrast-enhanced magnetic resonance imaging in the evaluation of the prostate.
    Bonekamp D; Macura KJ
    Top Magn Reson Imaging; 2008 Dec; 19(6):273-84. PubMed ID: 19512849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrent prostate cancer after external beam radiotherapy: value of contrast-enhanced dynamic MRI in localizing intraprostatic tumor--correlation with biopsy findings.
    Rouvière O; Valette O; Grivolat S; Colin-Pangaud C; Bouvier R; Chapelon JY; Gelet A; Lyonnet D
    Urology; 2004 May; 63(5):922-7. PubMed ID: 15134982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thirty-two-channel coil 3T magnetic resonance-guided biopsies of prostate tumor suspicious regions identified on multimodality 3T magnetic resonance imaging: technique and feasibility.
    Hambrock T; Fütterer JJ; Huisman HJ; Hulsbergen-vandeKaa C; van Basten JP; van Oort I; Witjes JA; Barentsz JO
    Invest Radiol; 2008 Oct; 43(10):686-94. PubMed ID: 18791410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Value of endorectal MRI and MRS in patients with elevated prostate-specific antigen levels and previous negative biopsies to localize peripheral zone tumours.
    Cirillo S; Petracchini M; Della Monica P; Gallo T; Tartaglia V; Vestita E; Ferrando U; Regge D
    Clin Radiol; 2008 Aug; 63(8):871-9. PubMed ID: 18625351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging.
    Uhl M; Saueressig U; van Buiren M; Kontny U; Niemeyer C; Köhler G; Ilyasov K; Langer M
    Invest Radiol; 2006 Aug; 41(8):618-23. PubMed ID: 16829744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of Gd-BOPTA and Gd-DTPA in contrast-enhanced MR imaging of the liver].
    Zhang HM; Ouyang H; Zhou CW
    Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):111-5. PubMed ID: 16750014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [MRI in cancer of the prostate with T1-weighted sequences using fat suppression and injection of gadolinium].
    Belin X; Cornud F; Fromont G; Melki P; Corréas JM; Hélénon O; Chrétien Y; Dufour B; Moreau JF
    J Radiol; 1994 Mar; 75(3):159-67. PubMed ID: 8176673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic value of contrast-enhanced fluid-attenuated inversion-recovery MRI for intracranial tumors in comparison with post-contrast T1W spin-echo MRI.
    Zhou ZR; Shen TZ; Chen XR; Peng WJ
    Chin Med J (Engl); 2006 Mar; 119(6):467-73. PubMed ID: 16584644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neural network approach to the segmentation and classification of dynamic magnetic resonance images of the breast: comparison with empiric and quantitative kinetic parameters.
    Szabó BK; Aspelin P; Wiberg MK
    Acad Radiol; 2004 Dec; 11(12):1344-54. PubMed ID: 15596372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
    Mendichovszky IA; Cutajar M; Gordon I
    Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.